About

OUR SERVICES

Health Economics

> Consulting

> Decision-Analytic Models

> Database Studies

> Clinical Trial-Based Economic Analyses

> Literature Reviews

Patient-Reported Outcomes

Market Access and Outcomes Strategy

Health Preference Assessment

Pharmacoepidemiology and Risk Management

Drug Safety and Pharmacovigilance

Biometrics

Clinical and Medical Services

RTI-HS Home › Our Services › Health Economics › Clinical-Trial Based Economic Analyses

Clinical-Trial Based Economic Analyses

Our clients understand the need to develop a health economic strategy early in development of new products. We help our clients incorporate health economic endpoints into clinical trials so that they are able to demonstrate the economic value of their drugs to HTA authorities, payers, physicians, patients and other stakeholders. Additionally, we provide health economic analysis of data from clinical trials and collaborate with clients on manuscripts and other reports.

	CONTACT US
	Stephen M Beard, MSc Vice President, Health Economics Stephanie R Earnshaw, PhD Vice President, US Health Economics Josephine A Mauskopf, PhD Vice President, Health Economics US: +1.800.262.3011 Spain: +34.93.241.7766 UK: +44(0)161.232.3400 For a full list of scientific staff bios, click here.

	Fact Sheets » Capturing the Patient's Perspective » Database Research » Global Value Dossiers » Health Economics » Health Preference Assessment